Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9503765 [patent_doc_number] => 08742081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Fluorescent GFP variant displaying highly increased fluorescence intensity without a spectral shift' [patent_app_type] => utility [patent_app_number] => 12/671495 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 12681 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671495 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671495
Fluorescent GFP variant displaying highly increased fluorescence intensity without a spectral shift Jul 31, 2008 Issued
Array ( [id] => 5574974 [patent_doc_number] => 20090142335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Methods of diagnosis and treatment of metabolic disorders' [patent_app_type] => utility [patent_app_number] => 12/220714 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14597 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142335.pdf [firstpage_image] =>[orig_patent_app_number] => 12220714 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/220714
Methods of diagnosis and treatment of metabolic disorders Jul 27, 2008 Abandoned
Array ( [id] => 9086147 [patent_doc_number] => 08557573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Vector particles for targeting CD34+ cells' [patent_app_type] => utility [patent_app_number] => 12/670479 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 7190 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670479 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670479
Vector particles for targeting CD34+ cells Jul 22, 2008 Issued
Array ( [id] => 6395717 [patent_doc_number] => 20100304353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHODS OF IMPROVING A GENOMIC MARKER INDEX OF DAIRY ANIMALS AND PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/669046 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13699 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20100304353.pdf [firstpage_image] =>[orig_patent_app_number] => 12669046 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/669046
METHODS OF IMPROVING A GENOMIC MARKER INDEX OF DAIRY ANIMALS AND PRODUCTS Jul 14, 2008 Abandoned
Array ( [id] => 8470037 [patent_doc_number] => 08299215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Methods and compositions for treating brain diseases' [patent_app_type] => utility [patent_app_number] => 12/172121 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 24 [patent_no_of_words] => 17101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12172121 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/172121
Methods and compositions for treating brain diseases Jul 10, 2008 Issued
Array ( [id] => 6551783 [patent_doc_number] => 20100233250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/665090 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13694 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665090 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/665090
VACCINE Jun 19, 2008 Abandoned
Array ( [id] => 4711116 [patent_doc_number] => 20080299642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'VECTORS WITH MODIFIED PROTEASE-DEPENDENT TROPISM' [patent_app_type] => utility [patent_app_number] => 12/140715 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 45865 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299642.pdf [firstpage_image] =>[orig_patent_app_number] => 12140715 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/140715
Vectors with modified protease-dependent tropism Jun 16, 2008 Issued
Array ( [id] => 6024932 [patent_doc_number] => 20110053258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Novel promoter sequence and the application thereof' [patent_app_type] => utility [patent_app_number] => 12/155393 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7368 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053258.pdf [firstpage_image] =>[orig_patent_app_number] => 12155393 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/155393
Novel promoter sequence and the application thereof Jun 2, 2008 Abandoned
Array ( [id] => 5272126 [patent_doc_number] => 20090075902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'INHIBITING THE SIGNS OF AGING BY INHIBITING NF-KAPPA B ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/126634 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9545 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075902.pdf [firstpage_image] =>[orig_patent_app_number] => 12126634 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/126634
INHIBITING THE SIGNS OF AGING BY INHIBITING NF-KAPPA B ACTIVATION May 22, 2008 Abandoned
Array ( [id] => 4739997 [patent_doc_number] => 20080233650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Method for propagating adenoviral vectors encoding inhibitory gene products' [patent_app_type] => utility [patent_app_number] => 12/118008 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13938 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233650.pdf [firstpage_image] =>[orig_patent_app_number] => 12118008 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/118008
Method for propagating adenoviral vectors encoding inhibitory gene products May 8, 2008 Abandoned
Array ( [id] => 5575477 [patent_doc_number] => 20090142839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells' [patent_app_type] => utility [patent_app_number] => 12/115451 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15556 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142839.pdf [firstpage_image] =>[orig_patent_app_number] => 12115451 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/115451
Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells May 4, 2008 Abandoned
Array ( [id] => 5452172 [patent_doc_number] => 20090068209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Cytotoxic Lymphocyte' [patent_app_type] => utility [patent_app_number] => 12/113822 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12441 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068209.pdf [firstpage_image] =>[orig_patent_app_number] => 12113822 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/113822
Cytotoxic T lymphocyte Apr 30, 2008 Issued
Array ( [id] => 5290450 [patent_doc_number] => 20090023180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Reduction of Shading in Microalgae' [patent_app_type] => utility [patent_app_number] => 12/099106 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17796 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023180.pdf [firstpage_image] =>[orig_patent_app_number] => 12099106 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/099106
Reduction of Shading in Microalgae Apr 6, 2008 Abandoned
Array ( [id] => 7811179 [patent_doc_number] => 08133709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Target sequences for synthetic molecules' [patent_app_type] => utility [patent_app_number] => 12/062031 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 14352 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133709.pdf [firstpage_image] =>[orig_patent_app_number] => 12062031 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/062031
Target sequences for synthetic molecules Apr 2, 2008 Issued
Array ( [id] => 6561057 [patent_doc_number] => 20100272691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Viruses' [patent_app_type] => utility [patent_app_number] => 12/670551 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 33248 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272691.pdf [firstpage_image] =>[orig_patent_app_number] => 12670551 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670551
Viruses Apr 1, 2008 Issued
Array ( [id] => 168025 [patent_doc_number] => 07666672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Cell lines' [patent_app_type] => utility [patent_app_number] => 12/020874 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12228 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666672.pdf [firstpage_image] =>[orig_patent_app_number] => 12020874 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/020874
Cell lines Jan 27, 2008 Issued
Array ( [id] => 6454716 [patent_doc_number] => 20100189729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'RNA-CODED ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/522214 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 33734 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189729.pdf [firstpage_image] =>[orig_patent_app_number] => 12522214 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522214
RNA-coded antibody Jan 7, 2008 Issued
Array ( [id] => 5508581 [patent_doc_number] => 20090081788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof' [patent_app_type] => utility [patent_app_number] => 12/000888 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 22461 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081788.pdf [firstpage_image] =>[orig_patent_app_number] => 12000888 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/000888
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof Dec 17, 2007 Abandoned
Array ( [id] => 5265527 [patent_doc_number] => 20090118212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES' [patent_app_type] => utility [patent_app_number] => 11/943871 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15649 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118212.pdf [firstpage_image] =>[orig_patent_app_number] => 11943871 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/943871
METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES Nov 20, 2007 Abandoned
Array ( [id] => 5380262 [patent_doc_number] => 20090192101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'CANCER-SPECIFIC PROMOTERS' [patent_app_type] => utility [patent_app_number] => 11/943057 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29544 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192101.pdf [firstpage_image] =>[orig_patent_app_number] => 11943057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/943057
CANCER-SPECIFIC PROMOTERS Nov 19, 2007 Abandoned
Menu